{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:36:43Z","timestamp":1784655403454,"version":"3.55.0"},"reference-count":79,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background and purpose: In the Netherlands, care for head and neck cancer (HNC) is centralised in head and neck oncology centres (HNOCs). Follow-up after treatment requires frequent visits that can burden patients and providers. Telemedicine, through remote evaluation of laryngopharyngoscopy videos recorded at local hospitals, may offer a feasible alternative. This study protocol describes the aim to assess patient satisfaction and safety with telemedicine follow-up after treatment of (pre-)malignant glottic lesions, including severe dysplasia, carcinoma-in-situ and T1 squamous cell carcinoma, conducted at one HNOC and participating general hospitals.\nMethods and analysis: As a non-blinded, randomised controlled trial, 90 patients with a one-way travel time by car of over 45 min to the HNOC will be allocated to the intervention group (follow-up by an Ear, Nose and Throat surgeon at a nearby participating hospital) or the control group (standard follow-up at the HNOC). All patients undergo guideline-based care. In the intervention group, laryngopharyngoscopy recordings will be remotely reviewed by HNOC specialists on the same day. Surveys will be fulfilled at baseline, 6 and 12 months. The primary outcome is overall patient satisfaction using a 0\u201310 numeric rating scale at 12 months follow-up. Secondary outcomes are safety, quality of life, fear of recurrence, travel time and carbon-dioxide emission. Safety will be assessed through recurrence, complications, re-referral and survival. Between-group and within-group comparisons will be performed to evaluate differences in outcomes, using appropriate statistical methods based on data distribution.\nEthics and dissemination: This study explores regional collaboration and sustainable follow-up for HNC patients. The ethics board approved the protocol (M23.325004). The authors commit to publishing the findings.<\/jats:p>","DOI":"10.2340\/1651-226x.2025.43947","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:37:33Z","timestamp":1754987853000},"page":"1035-1040","source":"Crossref","is-referenced-by-count":1,"title":["Telemedicine follow-up for pre-malignant and malignant glottic lesions: a randomised controlled trial study protocol comparing care close to home versus standard of care"],"prefix":"10.2340","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0457-9439","authenticated-orcid":false,"given":"Nathalie F.","family":"Van Rhee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3103-943X","authenticated-orcid":false,"given":"Rosanne C.","family":"Schoonbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-7224","authenticated-orcid":false,"given":"Inge","family":"Wegner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9257-2791","authenticated-orcid":false,"given":"Karin M.","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Maat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk A.","family":"Dietz de Loos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2460-2260","authenticated-orcid":false,"given":"Gy\u00f6rgy B.","family":"Halmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8631-7727","authenticated-orcid":false,"given":"Boudewijn E.C.","family":"Plaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"120440","doi-asserted-by":"crossref","unstructured":"Smith CDL, McMahon AD, Purkayastha M, Creaney G, Clements K, Inman GJ, et al. Head and neck cancer incidence is rising but the sociodemographic profile is unchanging: a population epidemiological study (2001\u20132020). BJC Rep. 2024;2(1):71.","DOI":"10.1038\/s44276-024-00089-z"},{"key":"120441","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s44276-024-00089-z","DOI":"10.1038\/s44276-024-00089-z"},{"key":"120442","unstructured":"Integraal Kankercentrum Nederland. National Dutch Cancer Registration (NKR) [Internet]. 2024 [cited 2025 Mar 7] Available from: https:\/\/iknl.nl\/nkr\/nkr-cijfers. [Dutch]"},{"key":"120443","doi-asserted-by":"crossref","unstructured":"Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med Sci (Basel). 2023;11(2):42.","DOI":"10.3390\/medsci11020042"},{"key":"120444","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/medsci11020042","DOI":"10.3390\/medsci11020042"},{"key":"120445","unstructured":"Nederlandse Vereniging voor Keel-Neus-Oorheelkunde en Heelkunde van het Hoofd-Halsgebied (NVKNO). Richtlijn Hoofd-halstumoren [Internet]. Utrecht; 2014 [cited 2025 Mar 7]. Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/hoofd-halstumoren_sept_2023. [Dutch]"},{"key":"120446","doi-asserted-by":"crossref","unstructured":"Venchiarutti RL, Pearce A, Mathers L, Dawson T, Ch\u2019ng S, Shannon K, et al. Travel-associated cost savings to patients and the health system through provision of specialist head and neck surgery outreach clinics in rural New South Wales, Australia. Aust J Rural Health. 2023;31(5):932\u201343.","DOI":"10.1111\/ajr.13021"},{"key":"120447","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ajr.13021","DOI":"10.1111\/ajr.13021"},{"key":"120448","doi-asserted-by":"crossref","unstructured":"Van Hof KS, Hoesseini A, Dorr MC, Verdonck-de Leeuw IM, Jansen F, Leemans CR, et al. Caregiver burden, psychological distress and quality of life among informal caregivers of patients with head and neck cancer: A longitudinal study. Int J Environ Res Public Health. 2022;19(23):16304.","DOI":"10.3390\/ijerph192316304"},{"key":"120449","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/ijerph192316304","DOI":"10.3390\/ijerph192316304"},{"key":"120450","unstructured":"Ministerie van Volksgezondheid, Welzijn en Sport. Integraal Zorgakkoord: \u2018Samen werken aan gezonde zorg\u2019 [Internet]. Den Haag; 2022 [cited 2025 Mar 7]. Available from: https:\/\/www.rijksoverheid.nl\/documenten\/rapporten\/2022\/09\/16\/integraal-zorgakkoord-samen-werken-aan-gezonde-zorg. [Dutch]"},{"key":"120451","doi-asserted-by":"crossref","unstructured":"Dretzke J, Lorenc A, Adriano A, Herd C, Mehanna H, Nankivell P, et al. Systematic review of patients\u2019 and healthcare professionals\u2019 views on patient-initiated follow-up in treated cancer patients. Cancer Med. 2023;12(15):16531\u201347.","DOI":"10.1002\/cam4.6243"},{"key":"120452","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/cam4.6243","DOI":"10.1002\/cam4.6243"},{"key":"120453","doi-asserted-by":"crossref","unstructured":"Lorenc A, Greaves C, Duda J, Brett J, Matheson L, Fulton-Lieuw T, et al. Exploring the views of patients\u2019 and their family about patient-initiated follow-up in head and neck cancer: a mixed methods study. Eur J Cancer Care (Engl). 2022;31(6):e13641.","DOI":"10.1111\/ecc.13641"},{"key":"120454","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ecc.13641","DOI":"10.1111\/ecc.13641"},{"key":"120455","doi-asserted-by":"crossref","unstructured":"Jefford M, Emery JD, James Martin A, De Abreu Lourenco R, Lisy K, Grunfeld E, et al. SCORE: a randomised controlled trial evaluating shared care (general practitioner and oncologist) follow-up compared to usual oncologist follow-up for survivors of colorectal cancer. EClinicalMedicine. 2023;66:102346.","DOI":"10.1016\/j.eclinm.2023.102346"},{"key":"120456","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102346","DOI":"10.1016\/j.eclinm.2023.102346"},{"key":"120457","doi-asserted-by":"crossref","unstructured":"Beaver K, Williamson S, Sutton C, Hollingworth W, Gardner A, Allton B, et al. Comparing hospital and telephone follow-up for patients treated for stage-I endometrial cancer (ENDCAT trial): a randomised, multicentre, non-inferiority trial. BJOG. 2017;124(1):150\u201360.","DOI":"10.1111\/1471-0528.14000"},{"key":"120458","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/1471-0528.14000","DOI":"10.1111\/1471-0528.14000"},{"key":"120459","doi-asserted-by":"crossref","unstructured":"Lewis RA, Neal RD, Hendry M, France B, Williams NH, Russell D, et al. Patients\u2019 and healthcare professionals\u2019 views of cancer follow-up: systematic review. Br J Gen Pract. 2009;59(564):e248\u201359.","DOI":"10.3399\/bjgp09X453576"},{"key":"120460","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3399\/bjgp09X453576","DOI":"10.3399\/bjgp09X453576"},{"key":"120461","doi-asserted-by":"crossref","unstructured":"van de Weerd C, van Tol-Geerdink JJ, van den Broek GB, Kaanders JHAM, Marres HAM, Hermens RPMG, et al. Individualised follow-up for head and neck cancer\u2014design of a prospective cohort study to assess its feasibility. BMJ Open. 2022;12(12):e068750.","DOI":"10.1136\/bmjopen-2022-068750"},{"key":"120462","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmjopen-2022-068750","DOI":"10.1136\/bmjopen-2022-068750"},{"key":"120463","doi-asserted-by":"crossref","unstructured":"Pakkanen P, Ilmarinen T, Halme E, Irjala H, Koivunen P, Pukkila M, et al. T1 glottic laryngeal cancer: the role of routine follow-up visits in detecting local recurrence. Eur Arch Otorhinolaryngol. 2021;278(12):4863\u20139.","DOI":"10.1007\/s00405-021-06983-3"},{"key":"120464","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00405-021-06983-3","DOI":"10.1007\/s00405-021-06983-3"},{"key":"120465","doi-asserted-by":"crossref","unstructured":"Hall SF, Owen T, Griffiths RJ, Brennan K. Does the frequency of routine follow-up after curative treatment for head-and-neck cancer affect survival? Curr Oncol. 2019;26(5):295\u2013306.","DOI":"10.3747\/co.26.4949"},{"key":"120466","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3747\/co.26.4949","DOI":"10.3747\/co.26.4949"},{"key":"120467","doi-asserted-by":"crossref","unstructured":"Zwakenberg MA, Westra JM, Halmos GB, Wedman J, van der Laan B, Plaat BEC. Narrow-band imaging in transoral laser surgery for early glottic cancer: a randomized controlled trial. Otolaryngol Head Neck Surg. 2023;169(3):606\u201314.","DOI":"10.1002\/ohn.307"},{"key":"120468","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/ohn.307","DOI":"10.1002\/ohn.307"},{"key":"120469","doi-asserted-by":"crossref","unstructured":"De Seta D, Campo F, D\u2019Aguanno V, Ralli M, Greco A, Russo FY, et al. Transoral laser microsurgery for Tis, T1, and T2 glottic carcinoma: 5-year follow-up. Lasers Med Sci. 2021;36(3):507\u201312.","DOI":"10.1007\/s10103-020-03049-4"},{"key":"120470","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s10103-020-03049-4","DOI":"10.1007\/s10103-020-03049-4"},{"key":"120471","doi-asserted-by":"crossref","unstructured":"Lei L, Zhong D, Zou J, Wang H, Yang H, Zhao Y, et al. Oncological outcomes of early stage glottic squamous cell carcinoma treated with transoral laser microsurgery. Am J Otolaryngol. 2020;41(2):102364.","DOI":"10.1016\/j.amjoto.2019.102364"},{"key":"120472","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.amjoto.2019.102364","DOI":"10.1016\/j.amjoto.2019.102364"},{"key":"120473","doi-asserted-by":"crossref","unstructured":"Canis M, Ihler F, Martin A, Matthias C, Steiner W. Transoral laser microsurgery for T1a glottic cancer: review of 404 cases. Head Neck. 2015;37(6):889\u201395.","DOI":"10.1002\/hed.23688"},{"key":"120474","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/hed.23688","DOI":"10.1002\/hed.23688"},{"key":"120475","doi-asserted-by":"crossref","unstructured":"Baird BJ, Sung CK, Beadle BM, Divi V. Treatment of early-stage laryngeal cancer: a comparison of treatment options. Oral Oncol. 2018;87:8\u201316.","DOI":"10.1016\/j.oraloncology.2018.09.012"},{"key":"120476","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.oraloncology.2018.09.012","DOI":"10.1016\/j.oraloncology.2018.09.012"},{"key":"120477","doi-asserted-by":"crossref","unstructured":"Scholman C, Westra JM, Zwakenberg MA, Dikkers FG, Halmos GB, Wedman J, et al. High-definition videolaryngoscopy is superior to fiberoptic laryngoscopy: a 111 multi-observer study. Eur Arch Otorhinolaryngol. 2021;278(6):1927\u201332.","DOI":"10.1007\/s00405-021-06673-0"},{"key":"120478","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00405-021-06673-0","DOI":"10.1007\/s00405-021-06673-0"},{"key":"120479","doi-asserted-by":"crossref","unstructured":"Cavanna L, Citterio C, Bosi C, Vecchia S, Proietto M, Mordenti P. Travel burden and carbon dioxide emission reductions through a model of cancer care closer to the patient. Oncologist. 2025;30(2):oya021.","DOI":"10.1093\/oncolo\/oyaf021"},{"key":"120480","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/oncolo\/oyaf021","DOI":"10.1093\/oncolo\/oyaf021"},{"key":"120481","doi-asserted-by":"crossref","unstructured":"Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346:f167.","DOI":"10.1136\/bmj.f167"},{"key":"120482","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmj.f167","DOI":"10.1136\/bmj.f167"},{"key":"120483","doi-asserted-by":"crossref","unstructured":"van Hof KS, Dulfer K, Sewnaik A, Baatenburg de Jong RJ, Offerman MPJ. The first steps in the development of a cancer-specific patient-reported experience measure item bank (PREM-item bank): towards dynamic evaluation of experiences. Support Care Cancer. 2024;32(2):100.","DOI":"10.1007\/s00520-023-08266-5"},{"key":"120484","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00520-023-08266-5","DOI":"10.1007\/s00520-023-08266-5"},{"key":"120485","doi-asserted-by":"crossref","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"120486","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.7326\/0003-4819-158-3-201302050-00583","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"120487","doi-asserted-by":"crossref","unstructured":"Kim ME, Sund LT, Morton M, Kim J, Choi JS, Castro ME. Provider and patient satisfaction with telemedicine voice therapy during the COVID-19 pandemic. J Voice. 2025;39(1):282 e19\u2013e27.","DOI":"10.1016\/j.jvoice.2022.07.009"},{"key":"120488","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jvoice.2022.07.009","DOI":"10.1016\/j.jvoice.2022.07.009"},{"key":"120489","doi-asserted-by":"crossref","unstructured":"McLaughlin EJ, Ellett LC, Readman E, Mooney S. Telehealth for gynaecology outpatients during the COVID-19 pandemic: patient and clinician experiences. Aust N Z J Obstet Gynaecol. 2022;62(4):553\u20139.","DOI":"10.1111\/ajo.13510"},{"key":"120490","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ajo.13510","DOI":"10.1111\/ajo.13510"},{"key":"120491","doi-asserted-by":"crossref","unstructured":"Rassouli F, Germann A, Baty F, Kohler M, Stolz D, Thurnheer R, et al. Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial. J Intern Med. 2021;289(3):404\u201310.","DOI":"10.1111\/joim.13230"},{"key":"120492","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/joim.13230","DOI":"10.1111\/joim.13230"},{"key":"120493","doi-asserted-by":"crossref","unstructured":"Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291(20):2441\u20137.","DOI":"10.1001\/jama.291.20.2441"},{"key":"120494","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jama.291.20.2441","DOI":"10.1001\/jama.291.20.2441"},{"key":"120495","doi-asserted-by":"crossref","unstructured":"Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol. 1999;17(3):1008\u201319.","DOI":"10.1200\/JCO.1999.17.3.1008"},{"key":"120496","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1200\/JCO.1999.17.3.1008","DOI":"10.1200\/JCO.1999.17.3.1008"},{"key":"120497","doi-asserted-by":"crossref","unstructured":"Versteegh MM, Vermeulen KM, Evers MAA, de Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19(4):343\u201352.","DOI":"10.1016\/j.jval.2016.01.003"},{"key":"120498","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jval.2016.01.003","DOI":"10.1016\/j.jval.2016.01.003"},{"key":"120499","doi-asserted-by":"crossref","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","DOI":"10.1007\/s11136-011-9903-x"},{"key":"120500","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s11136-011-9903-x","DOI":"10.1007\/s11136-011-9903-x"},{"key":"120501","doi-asserted-by":"crossref","unstructured":"Wind A, Hartman ED, Van Eekeren R, Wijn R, Hal\u00e1mkov\u00e1 J, Mattson J, et al. Validating a generic cancer consumer quality index in eight European countries, patient reported experiences and the influence of cultural differences. BMC Cancer. 2021;21(1):231.","DOI":"10.1186\/s12885-021-07943-0"},{"key":"120502","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12885-021-07943-0","DOI":"10.1186\/s12885-021-07943-0"},{"key":"120503","doi-asserted-by":"crossref","unstructured":"Custers JAE, Kwakkenbos L, van de Wal M, Prins JB, Thewes B. Re-validation and screening capacity of the 6-item version of the Cancer Worry Scale. Psychooncology. 2018;27(11):2609\u201315.","DOI":"10.1002\/pon.4782"},{"key":"120504","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/pon.4782","DOI":"10.1002\/pon.4782"},{"key":"120505","unstructured":"Zorginstituut Nederland. Voorbeelden van CQI- en PREM-vragenlijsten [Internet]. 2019 [cited 2025 Mar 7]. Available from: https:\/\/www.zorginzicht.nl\/ontwikkeltools\/ontwikkelen\/voorbeelden-van-cqi--en-prem-vragenlijsten. [Dutch]"},{"key":"120506","unstructured":"European Environment Agency (EEA). CO\u2082 emissions performance of new passenger cars in Europe [Internet]. Copenhagen; 2024 [cited 2025 Mar 7]. Available from: https:\/\/www.eea.europa.eu\/en\/analysis\/indicators\/co2-performance-of-new-passenger"},{"key":"120507","doi-asserted-by":"crossref","unstructured":"Hopewell S, Chan AW, Collins GS, Hr\u00f3bjartsson A, Moher D, Schulz KF, et al. CONSORT 2025 statement: updated guideline for reporting randomized trials. Nat Med. 2025;31:1776\u201383.","DOI":"10.1038\/s41591-025-03635-5"},{"key":"120508","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41591-025-03635-5","DOI":"10.1038\/s41591-025-03635-5"},{"key":"120509","doi-asserted-by":"crossref","unstructured":"Dhillon K, Manji J, Tapia C\u00e9spedes M, Prasad J, Kleid S, Flatman S, et al. Use of telemedicine consultations in head and neck cancer: patient perceptions, acceptability and accessibility. ANZ J Surg. 2022;92(6):1415\u201322.","DOI":"10.1111\/ans.17722"},{"key":"120510","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ans.17722","DOI":"10.1111\/ans.17722"},{"key":"120511","doi-asserted-by":"crossref","unstructured":"Ning AY, Cabrera CI, D\u2019Anza B. Telemedicine in otolaryngology: a systematic review of image quality, diagnostic concordance, and patient and provider satisfaction. Ann Otol Rhinol Laryngol. 2021;130(2):195\u2013204.","DOI":"10.1177\/0003489420939590"},{"key":"120512","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/0003489420939590","DOI":"10.1177\/0003489420939590"},{"key":"120513","doi-asserted-by":"crossref","unstructured":"Moentmann MR, Miller RJ, Chung MT, Yoo GH. Using telemedicine to facilitate social distancing in otolaryngology: a systematic review. J Telemed Telecare. 2023;29(5):331\u201348.","DOI":"10.1177\/1357633X20985391"},{"key":"120514","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/1357633X20985391","DOI":"10.1177\/1357633X20985391"},{"key":"120515","doi-asserted-by":"crossref","unstructured":"He Y, Cheng Y, Huang Z, Xu W, Hu R, Cheng L, et al. A deep convolutional neural network-based method for laryngeal squamous cell carcinoma diagnosis. Ann Transl Med. 2021;9(24):1797.","DOI":"10.21037\/atm-21-6458"},{"key":"120516","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.21037\/atm-21-6458","DOI":"10.21037\/atm-21-6458"},{"key":"120517","doi-asserted-by":"crossref","unstructured":"Wellenstein DJ, Woodburn J, Marres HAM, van den Broek GB. Detection of laryngeal carcinoma during endoscopy using artificial intelligence. Head Neck. 2023;45(9):2217\u201326.","DOI":"10.1002\/hed.27441"},{"key":"120518","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/hed.27441","DOI":"10.1002\/hed.27441"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/43947\/50985","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/43947\/50985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:04:34Z","timestamp":1756404274000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/43947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":79,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2025.43947","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}